Afuco™ Anti-Human FGFR2 ADCC Recombinant Antibody (BAY 1179470), ADCC Enhanced

CAT#: AFC-271CL

Anti-FGFR2 ADCC Enhanced Antibody (BAY 1179470) is an ADCC enhanced antibody produced by our Afuco™ platform. This is a novel fibroblast growth factor receptor 2 (FGFR2) directed antibody used for cancer therapy. FGFR2 is expressed in a range of tumor types such as gastric, breast, HNSCC, pancreatic and ovarian cancers. FGFR2 has been described to promote tumor growth and survival and play a role in chemotherapy resistance.

Gene Expression
Figure 1 IF staining of human cell line HEK 293 Figure 2 IHC staining of human stomach Figure 3 IHC staining of human skin Figure 4 Cerebral cortex Figure 5 Colon Figure 6 Testis Figure 7 Lymph node Figure 8 RNA cell line category: Cell line enhanced (AN3-CA, BEWO, CACO-2, HaCaT, HAP1, NTERA-2, T-47d)

Specifications

  • Host Species
  • Human
  • Type
  • ADCC enhanced antibody
  • Species Reactivity
  • Human
  • Related Disease
  • Cancer

Product Property

  • Purity
  • >95%, by SDS-PAGE, under reducing conditions
  • Storage
  • Store at -20°C. Open under aseptic conditions.

Target

  • Alternative Names
  • FGFR2; fibroblast growth factor receptor 2; BEK; JWS; BBDS; CEK3; CFD1; ECT1; KGFR; TK14; TK25; BFR-1; CD332; K-SAM; FGFR-2; FGF receptor; soluble FGFR4 variant 4; bacteria-expressed kinase; hydroxyaryl-protein kinase; FGFR2-AHCYL1 fusion kinase protein; keratinocyte growth factor receptor; BEK fibroblast growth factor receptor; protein tyrosine kinase, receptor like 14
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for AFC-271CL. Click the button above to contact us or submit your feedback about this product.
Breast cancer biomarkers at key points during disease progression
Excellent Specificity
This antibody provides exceptional specificity for FGFR2. I used it in Western Blot and obtained clean, distinct bands without any background noise. Highly recommend for targeted studies.
Breast cancer biomarkers at key points during disease progression
Impressive ADCC Activity
The ADCC enhancement is real and impactful. In our cell cytotoxicity assays, this antibody showed significantly improved efficacy compared to others. A great tool for functional studies.
Breast cancer biomarkers at key points during disease progression
Highly Specific
We were concerned about cross-reactivity, but this antibody proved to be very specific to FGFR2. It didn't pick up any other FGFR family members. Perfect for targeted research.

Q&As

  1. What is the specific target of the Afuco™ Anti-Human FGFR2 ADCC Recombinant Antibody?

    A: The antibody specifically targets the Fibroblast Growth Factor Receptor 2 (FGFR2), which plays a crucial role in developmental processes and tissue repair mechanisms.

  2. What kind of modifications have been made to enhance ADCC in this antibody?

    A: The antibody has been glyco-engineered to enhance its ability to recruit effector cells, thereby increasing its Antibody-Dependent Cellular Cytotoxicity (ADCC) activity.

  3. Why is the antibody labeled as "ADCC Enhanced?

    A: It has been modified to improve its interactions with Fc receptors on immune cells, thereby boosting its ability to mediate cell death through ADCC mechanisms.

View the frequently asked questions answered by Creative Biolabs Support.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Related Diseases

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

See other products for "FGFR2"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
IAB-B026(A) Recombinant Anti-human FGFR2 Intrabody [(D-Arg)9] IF, FC, FuncS scFv-(D-Arg)9
IAB-B026(G) Recombinant Anti-human FGFR2 Intrabody [+36 GFP] WB, ICC, FuncS scFv-(+36GFP)
IAB-B026(T) Recombinant Anti-human FGFR2 Intrabody [Tat] ICC, Neut, FuncS scFv-Tat
CAT Product Name Application Type
TAB-284CL Anti-Human FGFR2 Recombinant Antibody (BAY 1179470) IF, WB Antibody
CAT Product Name Application Type
MOR-1298 Hi-Affi™ Rabbit Anti-FGFR2 Recombinant Antibody (clone DS1298AB) WB, IP Rabbit IgG
CAT Product Name Application Type
VS-0325-FY132 Human Anti-FGFR2 (clone 4B9) scFv-Fc Chimera Inhib Human IgG1, scFv-Fc
CAT Product Name Application Type
VS-0425-YC624 Recombinant Anti-FGFR2 Vesicular Antibody, EV Displayed (VS-0425-YC624) ELISA, FC, Neut, Cell-uptake
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare